China approves two COVID-19 vaccines from Sinopharm's affiliate, CanSino
- Country:
- China
China's National Medical Products Administration said on Thursday that it has approved two more COVID-19 vaccines for public use.
The two vaccines are made by CanSino Biologics Inc and Sinopharm's affiliate Wuhan Institute of Biological Product.
The new approvals meant China had four locally developed approved vaccines for COVID-19.
ALSO READ
-
More Than Shorter Commute: How Compact Cities Can Help Migrant Workers Find Jobs
-
ILO Report Reveals How to Bring Social Security Within Reach of Informal Workers
-
WTO Sets Up Panel on EU Carbon Border Rules as Russia Challenges Restrictions
-
WHO Brings Global Experts Together to Strengthen Herbal Medicine Quality and Safety
-
Human Cost of Faster Work: Chinese Employees Weigh AI’s Promise Against Pay Fears
Google News